Share
We don’t often celebrate a graph (in fact I can’t remember ever doing it before!) but this one is well worth shouting about.
A couple of months back our prototype reader heated a DOSEmapper™ bead, counted the photons it emitted and plotted this “glow curve” graph. It is pretty much what everyone gets from a normal TLD (thermoluminescent dosimeter) reader so why the fuss? This one is from our utterly new design of reader which will read 100 micro silica DOSEmapper™ bead TLDs in about 15 minutes. Current TLD readers would take about 3 hours!
Our DOSEmapper™ technology and the reader will enable hospitals to quickly measure the actual dose of radiation received in-body at and around a patient’s tumour and compare it to the treatment plan. Clinicians can then correct any inaccuracies in the next session.
We have been supported for over a year by a great set of shareholders to develop this revolutionary new reader and, after the graph, it is now going into pre-production. That’s why a graph is well worth celebrating!
Related Posts
TRUEinvivo's 2018 achievements include prototype development, patent filings, fundraising, multiple awards, and market expansion, setting the stage for a busy 2019.
TrueInvivo's implant improves cancer treatment accuracy, accessible globally, supported by UKTI Sirius Programme.
Dr. Shakardokht Jafari named 2024 Innovator of the Year at Dynamic Awards in Brighton's Grand Hotel.
George Sutherland appointed TRUEinvivo Ltd.'s first Chairman, bringing extensive experience in medical devices and corporate finance.
